MedTrace Logo

Effects of Mother-infant Skin-to-skin Contact in Postpartum Women

NCT06781307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-08-14

No results posted yet for this study

Summary

When a newborn is delivered in good physiological condition, immediate skin-to-skin contact with the mother is required. Skin-to-skin contact has a wide range of benefits for both mother and baby. The implementation time can start from the birth of the newborn and continue until thereafter. There are benefits both in the short and long term, such as physiological stability, parent-child relationship development, and stability of children's behavioral development. There were 108 cases admitted and the attrition rate was 10%. Therefore, the total number of cases admitted was 118, divided into experimental groups and control groups, and intervention measures were implemented in the experimental group. From the 1st to the 30th day after delivery, there is 1 hour of skin-to-skin contact between mother and baby every day. Fill out the Sleep Quality Visual Analog Scale, Maternal Confidence Scale, and Mother-Infant Bonding Scale on the day after delivery and at one month later.

Conditions

  • Attachment

Interventions

OTHER

skin to skin

Intervention measures include 1 hour of skin-to-skin contact between mother and baby every day from day 1 to day 30 postpartum.

Sponsors & Collaborators

  • Jen-Ai Hospital Institutional Review Board

    lead INDUSTRY

Principal Investigators

  • TSAN-WEN HUANG, college · Jen-Ai Hospital Institutional Review Board

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-24
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06781307 on ClinicalTrials.gov